<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01477736</url>
  </required_header>
  <id_info>
    <org_study_id>OXITBALM</org_study_id>
    <nct_id>NCT01477736</nct_id>
  </id_info>
  <brief_title>A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor Overactivity</brief_title>
  <official_title>A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor Overactivity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro de Reabilitação e Readaptação Dr. Henrique Santillo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro de Reabilitação e Readaptação Dr. Henrique Santillo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effects of oral oxybutynin and intradetrusor
      injections of botulinum toxin type A on urodynamic parameters and quality of life in patients
      with neurogenic detrusor overactivity following spinal cord injury.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">November 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary study outcome measure was the variation mean in the number of episodes of urinary incontinence per 24 hours, maximum cystometric capacity, maximum detrusor pressure and bladder compliance</measure>
    <time_frame>Beginning and 24 weeks of the study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The secondary outcome measure was quality of life as measured by the Qualiveen questionnaire</measure>
    <time_frame>Beginning and 24 weeks of the study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Spinal Cord Injury</condition>
  <arm_group>
    <arm_group_label>Botulinum toxin A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>oxybutynin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxybutynin</intervention_name>
    <description>5 mg of immediate-release oxybutynin orally 3 times daily</description>
    <arm_group_label>Botulinum toxin A</arm_group_label>
    <arm_group_label>oxybutynin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum toxin A</intervention_name>
    <description>300 U intradetrusor injection</description>
    <arm_group_label>Botulinum toxin A</arm_group_label>
    <arm_group_label>oxybutynin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Spinal cord injury

          -  Detrusor overactivity

          -  Age over 18 years

          -  Spinal cord injury at least 12 months duration

          -  Undergoing regular clean intermittent catheterisation

        Exclusion Criteria:

          -  Pregnancy

          -  Desire to become pregnant during the study period

          -  Breastfeeding

          -  Blood coagulation disorder

          -  Neuromuscular transmission disorder

          -  Use of any intravesical pharmacologic agents

          -  Previous use of botulinum toxin A
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>RUITER S FERREIRA, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Division of Urology of State University of Campinas, Division of Urology of Centro de Reabilitaçao e Readapatacao Dr. Henrique Santillo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UNICAMP, Division of Urology</name>
      <address>
        <city>Campinas</city>
        <state>Sao Paulo</state>
        <zip>13083887</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://crer.org.br</url>
  </link>
  <link>
    <url>http://fcm.unicamp.br</url>
  </link>
  <reference>
    <citation>Karsenty G, Denys P, Amarenco G, De Seze M, Gamé X, Haab F, Kerdraon J, Perrouin-Verbe B, Ruffion A, Saussine C, Soler JM, Schurch B, Chartier-Kastler E. Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. Eur Urol. 2008 Feb;53(2):275-87. Epub 2007 Oct 16. Review.</citation>
    <PMID>17988791</PMID>
  </reference>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2011</study_first_submitted>
  <study_first_submitted_qc>November 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2011</study_first_posted>
  <last_update_submitted>November 19, 2011</last_update_submitted>
  <last_update_submitted_qc>November 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro de Reabilitação e Readaptação Dr. Henrique Santillo</investigator_affiliation>
    <investigator_full_name>Ruiter Silva Ferreira</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Neurogenic bladder</keyword>
  <keyword>Urodynamic</keyword>
  <keyword>Quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
    <mesh_term>Oxybutynin</mesh_term>
    <mesh_term>Mandelic Acids</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

